Abrocitinib may improve itch and quality of life in patients with itch-dominant atopic dermatitis.
Jonathan I SilverbergJacob P ThyssenIrina LazariciuDaniela E MyersErman GülerRaj ChovatiyaPublished in: Skin health and disease (2024)
NCT02780167; NCT03349060; NCT03575871; NCT03720470; NCT03422822.
Keyphrases